• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替考霉素,来自新放线菌(新种)的新型抗生素。I. 产生菌的描述、发酵研究及生物学特性

Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties.

作者信息

Parenti F, Beretta G, Berti M, Arioli V

出版信息

J Antibiot (Tokyo). 1978 Apr;31(4):276-83. doi: 10.7164/antibiotics.31.276.

DOI:10.7164/antibiotics.31.276
PMID:659325
Abstract

A soil isolate of Actinoplanes that produces the chemically unrelated new antibiotics teichomycins A1 and A2 has been proposed as a new species named Actinoplanes teichomyceticus nov. sp. (ATCC 31121). Studies of medium and fermentation conditions indicated that the highest antibiotic titers, ca 900 u/ml, are obtained in a medium containing 1% (w/v) glucose, 1% cotton seed meal, 1% malt extract, and 0.4% yeast extract. Both teichomycin A1 and teichomycin A2 are highly active against gram-positive bacteria. Teichomycin A1 shows some activity against gram-negative bacteria. Both antibiotics cured mice experimentally infected with sensitive bacteria and showed low acute toxicity. Of the two antibiotics teichomycin A2 is the more active.

摘要

从土壤中分离出的一株游动放线菌能产生化学结构不相关的新抗生素替考拉宁A1和A2,该菌株已被提议作为一个新物种,命名为替考拉宁游动放线菌新种(ATCC 31121)。对培养基和发酵条件的研究表明,在含有1%(w/v)葡萄糖、1%棉籽粉、1%麦芽提取物和0.4%酵母提取物的培养基中,抗生素产量最高,约为900单位/毫升。替考拉宁A1和替考拉宁A2对革兰氏阳性菌均有高度活性。替考拉宁A1对革兰氏阴性菌有一定活性。两种抗生素均能治愈实验性感染敏感菌的小鼠,且急性毒性较低。在这两种抗生素中,替考拉宁A2活性更强。

相似文献

1
Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties.替考霉素,来自新放线菌(新种)的新型抗生素。I. 产生菌的描述、发酵研究及生物学特性
J Antibiot (Tokyo). 1978 Apr;31(4):276-83. doi: 10.7164/antibiotics.31.276.
2
Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. II. Extraction and chemical characterization.替考霉素,来自新种替考游动放线菌的新型抗生素。II. 提取与化学特性分析。
J Antibiot (Tokyo). 1978 Mar;31(3):170-7. doi: 10.7164/antibiotics.31.170.
3
Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin).替考拉宁,来自新种游动放线菌(Actinoplanes teichomyceticus nov. sp.)的新型抗生素。IV. 替考拉宁(替考普肽)各组分的分离与特性分析
J Antibiot (Tokyo). 1984 Jun;37(6):615-20. doi: 10.7164/antibiotics.37.615.
4
Gardimycin, a new antibiotic from Actinoplanes. I. Description of the producer strain and fermentation studies.
J Antibiot (Tokyo). 1976 May;29(5):501-6. doi: 10.7164/antibiotics.29.501.
5
Lipiarmycin, a new antibiotic from Actinoplanes. I. Description of the producer strain and fermentation studies.
J Antibiot (Tokyo). 1975 Apr;28(4):247-52. doi: 10.7164/antibiotics.28.247.
6
Arizonins, a new complex of antibiotics related to kalafungin. I. Taxonomy of the producing culture, fermentation and biological activity.
J Antibiot (Tokyo). 1988 Sep;41(9):1205-11. doi: 10.7164/antibiotics.41.1205.
7
Friulimicins: novel lipopeptide antibiotics with peptidoglycan synthesis inhibiting activity from Actinoplanes friuliensis sp. nov. I. Taxonomic studies of the producing microorganism and fermentation.
J Antibiot (Tokyo). 2000 Aug;53(8):807-15. doi: 10.7164/antibiotics.53.807.
8
Coloradocin, an antibiotic from a new Actinoplanes. I. Taxonomy, fermentation and biological properties.
J Antibiot (Tokyo). 1987 Oct;40(10):1375-82. doi: 10.7164/antibiotics.40.1375.
9
A new aminoglycoside antibiotic complex--the seldomycins. I. Taxonomy, fermentation and antibacterial properties.
J Antibiot (Tokyo). 1977 Jan;30(1):17-24. doi: 10.7164/antibiotics.30.17.
10
New dithiolopyrrolone antibiotics from Saccharothrix sp. SA 233. I. Taxonomy, fermentation, isolation and biological activities.来自糖丝菌属菌株SA 233的新型二硫代吡咯烷酮类抗生素。I. 分类学、发酵、分离及生物活性。
J Antibiot (Tokyo). 2002 Aug;55(8):696-701. doi: 10.7164/antibiotics.55.696.

引用本文的文献

1
Discovery of thiazostatin D/E using UPLC-HR-MS2-based metabolomics and σ-factor engineering of sp. SE50/110.基于超高效液相色谱-高分辨质谱联用代谢组学及sp. SE50/110的σ因子工程发现噻唑他汀D/E
Front Bioeng Biotechnol. 2024 Nov 25;12:1497138. doi: 10.3389/fbioe.2024.1497138. eCollection 2024.
2
Therapeutic drug monitoring of glycopeptide antimicrobials: An overview of liquid chromatography-tandem mass spectrometry methods.糖肽类抗菌药物的治疗药物监测:液相色谱 - 串联质谱法概述
J Mass Spectrom Adv Clin Lab. 2023 Dec 22;31:33-39. doi: 10.1016/j.jmsacl.2023.12.003. eCollection 2024 Jan.
3
Synthetic and Semisynthetic Compounds as Antibacterials Targeting Virulence Traits in Resistant Strains: A Narrative Updated Review.
靶向耐药菌株毒力特性的合成及半合成抗菌化合物:一篇叙述性更新综述
Antibiotics (Basel). 2023 May 25;12(6):963. doi: 10.3390/antibiotics12060963.
4
Self-association of the glycopeptide antibiotic teicoplanin A2 in aqueous solution studied by molecular hydrodynamics.采用分子流体力学研究糖肽类抗生素替考拉宁 A2 在水溶液中的自缔合作用。
Sci Rep. 2023 Feb 3;13(1):1969. doi: 10.1038/s41598-023-28740-8.
5
Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview.靶向细菌细胞壁的抗生素和含碳水化合物药物:概述
Pharmaceuticals (Basel). 2022 Jul 29;15(8):942. doi: 10.3390/ph15080942.
6
Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L.糖肽类抗生素替考拉宁通过抑制组织蛋白酶L的蛋白水解活性来抑制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的细胞进入。
Front Microbiol. 2022 Apr 28;13:884034. doi: 10.3389/fmicb.2022.884034. eCollection 2022.
7
Pharmacokinetics and pharmacodynamics of peptide antibiotics.肽类抗生素的药代动力学和药效学。
Adv Drug Deliv Rev. 2022 Apr;183:114171. doi: 10.1016/j.addr.2022.114171. Epub 2022 Feb 18.
8
Bioinoculants-Natural Biological Resources for Sustainable Plant Production.生物菌剂——可持续植物生产的天然生物资源
Microorganisms. 2021 Dec 27;10(1):51. doi: 10.3390/microorganisms10010051.
9
Strain Improvement and Strain Maintenance Revisited. The Use of ATCC 31121 Protoplasts in the Identification of Candidates for Enhanced Teicoplanin Production.重新审视菌株改良与菌株保存:利用ATCC 31121原生质体鉴定替考拉宁产量提高的候选菌株
Antibiotics (Basel). 2021 Dec 27;11(1):24. doi: 10.3390/antibiotics11010024.
10
Teicoplanin-A New Use for an Old Drug in the COVID-19 Era?替考拉宁——一种老药在新冠疫情时代的新用途?
Pharmaceuticals (Basel). 2021 Nov 26;14(12):1227. doi: 10.3390/ph14121227.